ArticleCancer medicine2018

USP14 as a novel prognostic marker promotes cisplatin resistance via Akt/ERK signaling pathways in gastric cancer.

Ying Fu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.